Trial Condition(s):

Functional Gastrointestinal Disorders

Study to learn more about the stomach and intestine complaints of children aged from 3 to 14 years

Bayer Identifier:

20983

ClinicalTrials.gov Identifier:

NCT04029376

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In this observational study, researchers want to gain more information on children suffering from abnormal stomach and intestine function (based on the Rome criteria) and treated Iberogast. The Rome criteria have been developed by experts to support doctors to diagnose stomach and intestine disorders. This study will focus on children aged from 3 to 14 years in age treated by their doctor with the herbal drug Iberogast for their stomach and intestine complaints for one week. Researcher want to learn more about the efficacy of Iberogast by observing the changes of symptoms related to the stomach and intestine disorders. In addition information on the safety of the drug and how well the drug is tolerated by the patients will be collected.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
1032
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Iberogast (STW5, BAY98-7411)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many locations

Many locations, Germany

Status
Completed
 

Trial Design